相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RP-HPLC METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF EMPAGLIFLOZIN, PIOGLITAZONE, AND METFORMIN IN BULK AND TABLET DOSAGE FORMS
Razan Ahmad et al.
ACTA POLONIAE PHARMACEUTICA (2021)
What Are the Factors Associated with Nonadherence to Medications in Patients with Chronic Diseases?
Abdel Qader Al Bawab et al.
HEALTHCARE (2021)
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Ona Kinduryte Schorling et al.
ADVANCES IN THERAPY (2020)
Pharmacokinetics, Safety, and Bioequivalence of Two Empagliflozin Formulations after Single Oral Administration under Fasting and Fed Conditions in Healthy Chinese Subjects: An Open-label Randomized Single-dose Two-sequence, Two-treatment, Two-period Crossover Study
Gang Chen et al.
PHARMACOTHERAPY (2020)
Sample size determination in bioequivalence studies using statistical assurance
A. Ring et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Caroline Daems et al.
JOURNAL OF DIABETES RESEARCH (2019)
A complete review of empagliflozin: Most specific and potent SGLT2 inhibitor used for the treatment of type 2 diabetes mellitus
Gita Chawla et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Development and Validation of Liquid Chromatography Method for Determination of Glimepiride in Presence of (Vimto®) Soft Drinks in Rats: Application to Pharmacokinetics Studies
Mohammed Hamad et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2019)
How to adjust drug doses in chronic kidney disease
Maurizio Stefani et al.
AUSTRALIAN PRESCRIBER (2019)
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Christoph Wanner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi et al.
DIABETES CARE (2018)
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2017)
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
John E. Anderson et al.
DIABETES THERAPY (2017)
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
John E. Anderson et al.
DIABETES THERAPY (2017)
Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose
Muhammad Abdul-Ghani et al.
DIABETES (2017)
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Matthew J. Levine
CURRENT DIABETES REVIEWS (2017)
A Safety Evaluation of Empagliflozin for the Treatment of Type 2 Diabetes
Ian J. Neeland et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor
Andre J. Scheen
CLINICAL PHARMACOKINETICS (2014)
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers
Christian Friedrich et al.
CLINICAL THERAPEUTICS (2013)
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion Results of a randomized, placebo-controlled study
David Polidori et al.
DIABETES CARE (2013)
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial
Hans-Ulrich Haering et al.
DIABETES CARE (2013)
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
Muhammad A. Abdul-Ghani et al.
ENDOCRINE REVIEWS (2011)
Biology of Human Sodium Glucose Transporters
Ernest M. Wright et al.
PHYSIOLOGICAL REVIEWS (2011)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
分享论文
